Takeru Ehara

609 total citations
18 papers, 159 citations indexed

About

Takeru Ehara is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Takeru Ehara has authored 18 papers receiving a total of 159 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 6 papers in Oncology and 5 papers in Cancer Research. Recurrent topics in Takeru Ehara's work include Peptidase Inhibition and Analysis (5 papers), Radiopharmaceutical Chemistry and Applications (3 papers) and Protease and Inhibitor Mechanisms (3 papers). Takeru Ehara is often cited by papers focused on Peptidase Inhibition and Analysis (5 papers), Radiopharmaceutical Chemistry and Applications (3 papers) and Protease and Inhibitor Mechanisms (3 papers). Takeru Ehara collaborates with scholars based in Japan, Switzerland and Germany. Takeru Ehara's co-authors include Hiroyuki Akita, Machiko Ono, Takatoshi Kosaka, Hideo Nakamura, Minoru Maëda, Fumiaki Yokokawa, Naoki Teno, Ichiro Umemura, M. Mason Guest and Keiichi Masuya and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Journal of Medicinal Chemistry.

In The Last Decade

Takeru Ehara

17 papers receiving 154 citations

Peers

Takeru Ehara

ONCOL

RNMI

Jean-Pierre Evenou Switzerland

Seung Tae Kim South Korea

David Koditek United States

Rena Zhang United States

Christopher M. Russo United States

Elda Meta Italy

Minna Bui United States

Tzu‐Lan Yeh United Kingdom

Melinda Broward United States

Yanyan Tudor United States

Jean-Pierre Evenou Switzerland

Takeru Ehara

190 ×2.6

79 ×1.4

59 ×2.0

ONCOL

8 ×0.3

RNMI

13 ×0.5

Citations per year, relative to Takeru Ehara Takeru Ehara (= 1×) peers Jean-Pierre Evenou

Countries citing papers authored by Takeru Ehara

Since Specialization

Citations

This map shows the geographic impact of Takeru Ehara's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Takeru Ehara with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Takeru Ehara more than expected).

Fields of papers citing papers by Takeru Ehara

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Takeru Ehara. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Takeru Ehara. The network helps show where Takeru Ehara may publish in the future.

Co-authorship network of co-authors of Takeru Ehara

This figure shows the co-authorship network connecting the top 25 collaborators of Takeru Ehara. A scholar is included among the top collaborators of Takeru Ehara based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Takeru Ehara. Takeru Ehara is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

Reschke, Markus, Danielle Park, Sarah Choi, et al.. (2025). Abstract ND07: FXX489, a FAP targeting ligand with best-in-class potential for radioligand therapy. Cancer Research. 85(8_Supplement_2). ND07–ND07. 1 indexed citations

Lin, Fanching, Takeru Ehara, Steven V. Horton, et al.. (2024). Peptide Binder to Glypican-3 as a Theranostic Agent for Hepatocellular Carcinoma. Journal of Nuclear Medicine. 65(4). 586–592. 29 indexed citations

Lin, Fanching, Takeru Ehara, Steven V. Horton, et al.. (2024). Novel GPC3-targeting radiopharmaceutical therapy for hepatocellular carcinoma.. Journal of Clinical Oncology. 42(3_suppl). 525–525. 3 indexed citations

Suzuki, Kentaro, et al.. (2024). Abstract 6024: A novel carbonic anhydrase IX targeting radiopeptide, 64Cu-PD-32766 and 177Lu-PD-32766, exhibit promising theranostic potential in ccRCC tumors. Cancer Research. 84(6_Supplement). 6024–6024. 1 indexed citations

Li, Gary, Fanching Lin, Takeru Ehara, et al.. (2023). Novel peptide binder to Glypican-3 for targeted radiopharmaceutical therapy of hepatocellular carcinoma.. Journal of Clinical Oncology. 41(16_suppl). e16131–e16131. 1 indexed citations

Richardson, Samantha J., Takeru Ehara, M. Mason Guest, et al.. (2023). Novel peptide binder for EphA2-targeted radiopharmaceutical therapy for multiple solid tumors.. Journal of Clinical Oncology. 41(16_suppl). e15113–e15113.

Argikar, Upendra A., Christopher M. Adams, Ganesh Prasanna, et al.. (2020). Understanding metabolism related differences in ocular efficacy of MGV354. Xenobiotica. 51(1). 5–14. 2 indexed citations

Prasanna, Ganesh, Luciana Ferrara, Christopher M. Adams, et al.. (2018). A Novel Selective Soluble Guanylate Cyclase Activator, MGV354, Lowers Intraocular Pressure in Preclinical Models, Following Topical Ocular Dosing. Investigative Ophthalmology & Visual Science. 59(5). 1704–1704. 16 indexed citations

Ehara, Takeru, Takatoshi Kosaka, Takanori Kanazawa, et al.. (2014). Structure-Based Design of Substituted Piperidines as a New Class of Highly Efficacious Oral Direct Renin Inhibitors. ACS Medicinal Chemistry Letters. 5(7). 787–792. 10 indexed citations

10.

Artman, Gerald D., Christopher M. Adams, Martin Dimitroff, et al.. (2010). One-pot synthesis of 2-aminobenzimidazoles using 2-chloro-1,3-dimethylimidazolinium chloride (DMC). Tetrahedron Letters. 51(40). 5319–5321. 4 indexed citations

11.

Ehara, Takeru, Fumiaki Yokokawa, Junichi Sakaki, et al.. (2008). Discovery of selective and nonpeptidic cathepsin S inhibitors. Bioorganic & Medicinal Chemistry Letters. 18(14). 3959–3962. 14 indexed citations

12.

Yokokawa, Fumiaki, Takeru Ehara, Yuki Iwaki, et al.. (2008). 4-Amino-2-cyanopyrimidines: Novel scaffold for nonpeptidic cathepsin S inhibitors. Bioorganic & Medicinal Chemistry Letters. 18(16). 4642–4646. 10 indexed citations

13.

Teno, Naoki, Keiichi Masuya, Takeru Ehara, et al.. (2008). Effect of Cathepsin K Inhibitors on Bone Resorption. Journal of Medicinal Chemistry. 51(17). 5459–5462. 18 indexed citations

14.

Ehara, Takeru, et al.. (2007). Synthesis of (R)-Curcumene and (R)-Xanthorrizol Based on 1,2-Aryl Migration via Phenonium Ion. Chemical and Pharmaceutical Bulletin. 55(9). 1361–1364. 19 indexed citations

15.

Akita, Hiroyuki, et al.. (2007). Total Synthesis of (S)-(+)- and (R)-(-)-Curcudiols Based on 1,2-Aryl Migration via Phenonium Ion. Heterocycles. 71(3). 627–627. 8 indexed citations

16.

Ono, Machiko, et al.. (2005). Solvolysis of (4,5)-anti-4-Aryl-5-tosyloxy-2(E)-hexenoate Derivatives. Chemical and Pharmaceutical Bulletin. 53(10). 1259–1265. 6 indexed citations

17.

Ehara, Takeru, Md. Rowshon Alam, Yasuhiro Fujino, et al.. (2001). Solid-Phase synthesis of a library constructed of aromatic phosphate, long alkyl chains and tryptophane components, and identification of potent dipeptide telomerase inhibitors. Bioorganic & Medicinal Chemistry Letters. 11(19). 2581–2584. 2 indexed citations

18.

Ehara, Takeru, et al.. (2001). Development of novel telomerase inhibitors based on a Bisindole unit. Bioorganic & Medicinal Chemistry Letters. 11(4). 583–585. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact